Pershing Edward — SEC Form 4 filings
SEC reporting owner CIK 1689739. 101 Form 4 filings on record with FilingPulse; latest filed 2026-09-18.
Transaction summary — filings shown
Covers the 50 most recent of 101 filings on record, filed 2025-05-27 to 2026-09-18. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 73.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| PROVECTUS BIOPHARMACEUTICALS, INC. (PVCT) | CEO, Director, 10% owner | 50 | — | — | 73 |
Form 4 filings — Pershing Edward
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-18 | 4 | PROVECTUS BIOPHARMACEUTICALS, INC. (PVCT) | Option exercise (M) @ $0 · Option exercise (M): 13,216 (derivative) @ $0 | EDGAR |
| 2026-09-11 | 4 | PROVECTUS BIOPHARMACEUTICALS, INC. (PVCT) | Option exercise (M) @ $0 · Option exercise (M): 13,216 (derivative) @ $0 | EDGAR |
| 2026-09-08 | 4 | PROVECTUS BIOPHARMACEUTICALS, INC. (PVCT) | Option exercise (M) @ $0 · Option exercise (M): 11,328 (derivative) @ $0 | EDGAR |
| 2026-08-26 | 4 | PROVECTUS BIOPHARMACEUTICALS, INC. (PVCT) | Option exercise (M) @ $0 · Option exercise (M): 11,328 (derivative) @ $0 | EDGAR |
| 2026-07-02 | 4 | PROVECTUS BIOPHARMACEUTICALS, INC. (PVCT) | Grant/award (A): 45,860 (derivative) @ $0 | EDGAR |
| 2026-06-05 | 4 | PROVECTUS BIOPHARMACEUTICALS, INC. (PVCT) | Option exercise (M) @ $0 · Option exercise (M): 9,436 (derivative) @ $0 | EDGAR |
| 2026-05-29 | 4 | PROVECTUS BIOPHARMACEUTICALS, INC. (PVCT) | Grant/award (A) @ $0 | EDGAR |
| 2026-05-26 | 4 | PROVECTUS BIOPHARMACEUTICALS, INC. (PVCT) | Option exercise (M) @ $0 · Option exercise (M): 32,089 (derivative) @ $0 | EDGAR |
| 2026-05-15 | 4 | PROVECTUS BIOPHARMACEUTICALS, INC. (PVCT) | Option exercise (M) @ $0 · Option exercise (M): 22,651 (derivative) @ $0 | EDGAR |
| 2026-05-07 | 4 | PROVECTUS BIOPHARMACEUTICALS, INC. (PVCT) | Option exercise (M) @ $0 · Option exercise (M): 18,876 (derivative) @ $0 | EDGAR |
| 2026-04-29 | 4 | PROVECTUS BIOPHARMACEUTICALS, INC. (PVCT) | Option exercise (M) @ $0 · Option exercise (M): 30,202 (derivative) @ $0 | EDGAR |
| 2026-04-06 | 4 | PROVECTUS BIOPHARMACEUTICALS, INC. (PVCT) | Option exercise (M) @ $0 · Option exercise (M): 33,977 (derivative) @ $0 | EDGAR |
| 2026-03-26 | 4 | PROVECTUS BIOPHARMACEUTICALS, INC. (PVCT) | Grant/award (A) @ $0 | EDGAR |
| 2026-03-20 | 4 | PROVECTUS BIOPHARMACEUTICALS, INC. (PVCT) | Option exercise (M) @ $0 · Option exercise (M): 49,067 (derivative) @ $0 | EDGAR |
| 2026-03-16 | 4 | PROVECTUS BIOPHARMACEUTICALS, INC. (PVCT) | Grant/award (A) @ $0 | EDGAR |
| 2026-03-06 | 4 | PROVECTUS BIOPHARMACEUTICALS, INC. (PVCT) | Grant/award (A) @ $0 | EDGAR |
| 2026-02-27 | 4 | PROVECTUS BIOPHARMACEUTICALS, INC. (PVCT) | Grant/award (A) @ $0 | EDGAR |
| 2026-02-23 | 4 | PROVECTUS BIOPHARMACEUTICALS, INC. (PVCT) | Grant/award (A) @ $0 | EDGAR |
| 2026-02-23 | 4 | PROVECTUS BIOPHARMACEUTICALS, INC. (PVCT) | Option exercise (M) @ $0 · Option exercise (M): 47,180 (derivative) @ $0 | EDGAR |
| 2026-02-17 | 4 | PROVECTUS BIOPHARMACEUTICALS, INC. (PVCT) | Grant/award (A) @ $0 | EDGAR |
| 2026-02-11 | 4 | PROVECTUS BIOPHARMACEUTICALS, INC. (PVCT) | Purchase (P): 34,940 (derivative) @ $2.86 | EDGAR |
| 2026-02-09 | 4 | PROVECTUS BIOPHARMACEUTICALS, INC. (PVCT) | Grant/award (A) @ $0 | EDGAR |
| 2026-02-02 | 4 | PROVECTUS BIOPHARMACEUTICALS, INC. (PVCT) | Option exercise (M) @ $0 · Option exercise (M): 37,744 (derivative) @ $0 | EDGAR |
| 2026-01-29 | 4 | PROVECTUS BIOPHARMACEUTICALS, INC. (PVCT) | Grant/award (A) @ $0 | EDGAR |
| 2026-01-16 | 4 | PROVECTUS BIOPHARMACEUTICALS, INC. (PVCT) | Option exercise (M) @ $0 · Option exercise (M): 37,744 (derivative) @ $0 | EDGAR |
| 2025-12-15 | 4 | PROVECTUS BIOPHARMACEUTICALS, INC. (PVCT) | Grant/award (A) @ $0 | EDGAR |
| 2025-12-08 | 4 | PROVECTUS BIOPHARMACEUTICALS, INC. (PVCT) | Grant/award (A) @ $0 | EDGAR |
| 2025-11-28 | 4 | PROVECTUS BIOPHARMACEUTICALS, INC. (PVCT) | Grant/award (A) @ $0 | EDGAR |
| 2025-11-21 | 4 | PROVECTUS BIOPHARMACEUTICALS, INC. (PVCT) | Grant/award (A) @ $0 | EDGAR |
| 2025-11-14 | 4 | PROVECTUS BIOPHARMACEUTICALS, INC. (PVCT) | Grant/award (A) @ $0 | EDGAR |
| 2025-11-07 | 4 | PROVECTUS BIOPHARMACEUTICALS, INC. (PVCT) | Grant/award (A) @ $0 | EDGAR |
| 2025-10-31 | 4 | PROVECTUS BIOPHARMACEUTICALS, INC. (PVCT) | Grant/award (A) @ $0 | EDGAR |
| 2025-10-24 | 4 | PROVECTUS BIOPHARMACEUTICALS, INC. (PVCT) | Grant/award (A) @ $0 | EDGAR |
| 2025-10-17 | 4 | PROVECTUS BIOPHARMACEUTICALS, INC. (PVCT) | Option exercise (M) @ $0 · Option exercise (M): 18,880 (derivative) @ $0 | EDGAR |
| 2025-10-14 | 4 | PROVECTUS BIOPHARMACEUTICALS, INC. (PVCT) | Grant/award (A) @ $0 | EDGAR |
| 2025-10-09 | 4 | PROVECTUS BIOPHARMACEUTICALS, INC. (PVCT) | Grant/award (A) @ $0 | EDGAR |
| 2025-09-30 | 4 | PROVECTUS BIOPHARMACEUTICALS, INC. (PVCT) | Option exercise (M) @ $0 · Option exercise (M): 66,052 (derivative) @ $0 | EDGAR |
| 2025-09-19 | 4 | PROVECTUS BIOPHARMACEUTICALS, INC. (PVCT) | Grant/award (A) @ $0 | EDGAR |
| 2025-09-19 | 4 | PROVECTUS BIOPHARMACEUTICALS, INC. (PVCT) | Option exercise (M) @ $0 · Option exercise (M): 37,760 (derivative) @ $0 | EDGAR |
| 2025-09-12 | 4 | PROVECTUS BIOPHARMACEUTICALS, INC. (PVCT) | Grant/award (A) @ $0 | EDGAR |
| 2025-09-05 | 4 | PROVECTUS BIOPHARMACEUTICALS, INC. (PVCT) | Grant/award (A) @ $0 | EDGAR |
| 2025-08-29 | 4 | PROVECTUS BIOPHARMACEUTICALS, INC. (PVCT) | Option exercise (M) @ $0 · Option exercise (M): 28,320 (derivative) @ $0 | EDGAR |
| 2025-08-27 | 4 | PROVECTUS BIOPHARMACEUTICALS, INC. (PVCT) | Grant/award (A) @ $0 | EDGAR |
| 2025-08-22 | 4 | PROVECTUS BIOPHARMACEUTICALS, INC. (PVCT) | Option exercise (M) @ $0 · Option exercise (M): 37,760 (derivative) @ $0 | EDGAR |
| 2025-08-12 | 4 | PROVECTUS BIOPHARMACEUTICALS, INC. (PVCT) | Option exercise (M) @ $0 · Option exercise (M): 18,880 (derivative) @ $0 | EDGAR |
| 2025-07-21 | 4 | PROVECTUS BIOPHARMACEUTICALS, INC. (PVCT) | Option exercise (M) @ $0 · Option exercise (M): 62,303 (derivative) @ $0 | EDGAR |
| 2025-06-26 | 4 | PROVECTUS BIOPHARMACEUTICALS, INC. (PVCT) | Option exercise (M) @ $0 · Option exercise (M): 122,692 (derivative) @ $0 | EDGAR |
| 2025-06-23 | 4 | PROVECTUS BIOPHARMACEUTICALS, INC. (PVCT) | Option exercise (M) @ $0 · Option exercise (M): 18,880 (derivative) @ $0 | EDGAR |
| 2025-06-06 | 4 | PROVECTUS BIOPHARMACEUTICALS, INC. (PVCT) | Grant/award (A) @ $0 | EDGAR |
| 2025-05-27 | 4 | PROVECTUS BIOPHARMACEUTICALS, INC. (PVCT) | Grant/award (A) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1689739 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →